OBJECTIVE The treatment for superficial G3 transitional cell carcinoma (TCC) of the urinary bladder remains controversial. It is important to reveal the clinical features of superficial G3 bladder cancer that can be treated conservatively. PATIENTS AND METHODS A total of 39 patients with primary superficial bladder cancer (Ta, T1) with G3 components but without concomitant carcinoma in situ (...

There are no guidelines regarding whether to perform either a radical transurethral resection of the bladder tumor (TUR-BT) or a total cystectomy after TUR biopsy for huge bladder cancer, and this decision is entrusted to each institution. Of 439 patients in whom TUR-BT was performed from 2005 through 2009, the weight of the total resected volume was > 50 g in 6 patients, and among these 6 pati...

PURPOSE To characterize age-related clinical and urodynamic features of patients with benign prostatic hyperplasia (BPH) treated by transurethral resection of the prostate (TUR-P). MATERIALS AND METHODS Between July 1994 and March 2000, a total number of 451 patients underwent TUR-P in Nagoya Urology Hospital. Out of these 451 patients, 15 (3.3%) were diagnosed as having an incidental prostat...

Constantine Kontoghiorghes is an Assistant Professor of management and Organizational Behavior at the Cyprus International Institute of Management. His current research and consulting work focuses on the design of high performance work systems with particular emphasis on change management, organization competitiveness, innovation, technology management, quality and productivity improvement , em...

Of all the patients who present with bladder cancer, approximately 75–85% present with disease confined to the mucosa (stage Tis carcinoma in situ [CIS] or stage Ta) or submucosa (stage T1). These groups of bladder cancer are referred to as non–muscleinvasive or superficial bladder cancer, in contrast with muscle-invasive bladder cancer (stage T2, or advanced stage T3–T4). These anatomic classi...

INTRODUCTION Transurethral resection (TUR) is the most common surgical technique for the diagnosis and initial treatment of bladder cancer. In this study, we evaluated two surgical techniques in terms of bladder injury due to obturator reflex in patients that underwent TUR for non-muscle invasive bladder cancer (NMIBC). MATERIAL AND METHODS 93 patients who underwent TUR for bladder cancer wer...

OBJECTIVE To ascertain the effect of intravesical instillation of Alpha 2-b Interferon (IFN a-2) 10 million I.U. in 50 ml physiological saline as a monotherapy and in combination with Farmarubicin (FRC) 50 mg dissolved together in 50 ml of physiological saline. These substances were administered four times during the first month after TUR-BT and then once monthly for one year either in the form...

Objective: We investigated the clinical markers for the prediction of residual tumors at repeat transurethral resection (re-TUR) for patients with T1 bladder cancer and evaluated the effect of the residual tumor on the prognosis of the disease. Methods: We reviewed the clinical data of the patients undergoing transurethral resection of bladder tumor (TURBT) from 2008 to 2015 in our department. ...